The Lung Cancer Therapeutics Market is predicted to reach US$ by 2030 from US$ 9.9 billion in 2021, and to grow at a CAGR of 10.70% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
By Disease Type (Small cell Lung Cancer (SCLC), Non-small Cell lung Cancer (NSCLC)), By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Bristol-Myers Squibb Company, F. Hoffman-La Roche Ltd., Pfizer Inc., Eli Lilly and Company, Johnson & Johnson Services, Inc., Amgen Inc., AstraZeneca plc., Teva Pharmaceutical Industries Ltd., Abbvie Inc., Novartis AG, Merck & Co., Inc. and GSK plc among others
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Lung Cancer Therapeutics - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Lung Cancer Therapeutics - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Lung Cancer Therapeutics - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Lung Cancer Therapeutics - ANALYSIS & FORECAST, BY REGION
North America Lung Cancer Therapeutics
1. North America Lung Cancer Therapeutics , by Country
1. US
2. Canada
1. North America Lung Cancer Therapeutics , by Product
2. North America Lung Cancer Therapeutics , by Type
3. North America Lung Cancer Therapeutics , by Gender
4. North America Lung Cancer Therapeutics , by Sales Channel
3. Europe Lung Cancer Therapeutics
1. Europe Lung Cancer Therapeutics , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Lung Cancer Therapeutics , by Product
3. Europe Lung Cancer Therapeutics , by Type
4. Europe Lung Cancer Therapeutics , by Gender
5. Europe Lung Cancer Therapeutics , by Sales Channel
4. Asia Pacific Lung Cancer Therapeutics
1. Asia Pacific Lung Cancer Therapeutics , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Lung Cancer Therapeutics , by product
3. Asia Pacific Lung Cancer Therapeutics , by Type
4. Asia Pacific Lung Cancer Therapeutics , by Gender
5. Asia Pacific Lung Cancer Therapeutics , by Sales Channel
5. Rest of the World Lung Cancer Therapeutics
1. Rest of the World Lung Cancer Therapeutics , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Lung Cancer Therapeutics , by Product
3. Rest of the World Lung Cancer Therapeutics , by Type
4. Rest of the World Lung Cancer Therapeutics , by Gender
5. Rest of the World Lung Cancer Therapeutics , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 54
Overview of the Global Advanced Cancer Care Coordination Market:
The report discusses everything a marketer requires before investing in the global Advanced Cancer Care Coordination Market during the forecast period...
Overview of the Global Online Cancer Patient Registry Software Market:
The report discusses everything a marketer requires before investing in the global Online Cancer Patient Registry Software Market during the for...
Overview of the Global Cancer Pain Management Software Market:
The report discusses everything a marketer requires before investing in the global Cancer Pain Management Software Market during the forecast period 202...
Overview of the Global Holistic Mindfulness Cancer Care Management Market:
The report discusses everything a marketer requires before investing in the global Holistic Mindfulness Cancer Care Management Market during...
Overview of the Global Cancer Registry Management Solutions Market:
The report discusses everything a marketer requires before investing in the global Cancer Registry Management Solutions Market during the forecast ...
Overview of the Global Cancer Registry Quality Control Software Market:
The report discusses everything a marketer requires before investing in the global Cancer Registry Quality Control Software Market during the f...
Overview of the Global Early Cancer Screening Technologies Market:
The report discusses everything a marketer requires before investing in the global Early Cancer Screening Technologies Market during the forecast pe...
Overview of the Global Advanced Therapeutics Pharmaceutical Outsourcing Market:
The report discusses everything a marketer requires before investing in the global Advanced Therapeutics Pharmaceutical Outsourcing Mar...
Overview of the Global ESR1 Mutated Metastatic Breast Cancer Diagnostics Market:
The report discusses everything a marketer requires before investing in the global ESR1 Mutated Metastatic Breast Cancer Diagnostics M...
Executive Summary
Azoth Analytics has released a research report titled "Cystic Fibrosis Lung Disease Market (2024 Edition)" which provides a complete analysis of the global Cystic Fibrosis Lung Disease industry in terms of market segmentation by Drug Type (CFTR Modulators, Bronchodilat...